Inventor
BERZOFSKY JAY A
US48 patents
⚠️ This page may combine multiple inventors who share the name “BERZOFSKY JAY A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
35 patentsUS6592872B1Jul 15, 2003
Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein
US HEALTH62 citations94
US5939074AAug 17, 1999
Multideterminant peptide antigens
US HEALTH24 citations92
US7094405B1Aug 22, 2006
Peptides which elicit a high neutralizing antibody titer, cytotoxic T lymphocyte response and T helper cell response in a broad range of MHC type recipients
US HEALTH14 citations90
US6749856B1Jun 15, 2004
Mucosal cytotoxic T lymphocyte responses
US HEALTH54 citations90
US6294322B1Sep 25, 2001
Multideterminant peptides that elicit helper T-lymphocyte cytotoxic T-lymphocyte and neutralizing antibody responses against HIV-1
US HEALTH20 citations90
US5997869ADec 7, 1999
Peptides containing a fusion joint of a chimeric protein encoded by DNA spanning a tumor-associated chromosomal translocation and their use as immunogens
US HEALTH26 citations89
US5932218AAug 3, 1999
Multideterminant peptides eliciting helper T-lymphocyte, cytotoxic T-lymphocyte, and neutralizing antibody responses against HIV-1
US HEALTH21 citations88
US5081226AJan 14, 1992
Synthetic peptides sharing sequence homology with the HIV envelope protein
US HEALTH25 citations87
US5336758AAug 9, 1994
Peptides stimulating cytotoxic T cells immune to HIV RT
US HEALTH23 citations86
US5030449AJul 9, 1991
Synthetic vaccine against AIDS virus
US HEALTH38 citations86
US7097965B2Aug 29, 2006
Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein
US HEALTH11 citations82
US5820865AOct 13, 1998
Method to induce cytotoxic T Lymphocytes specific for a broad array of HIV-1 isolates using hybrid synthetic peptides
US HEALTH5 citations73
US5711947AJan 27, 1998
Method to induce cytotoxic T Lymphocytes specific for a broad array of HIV-1 isolates using hybrid synthetic peptides
US HEALTH5 citations73
US6214347B1Apr 10, 2001
Multideterminant peptides that elicit helper T-lymphocyte, cytotoxic T lymphocyte and neutralizing antibody responses against HIV-1
US HEALTH5 citations71
US5028425AJul 2, 1991
Synthetic vaccine against P. falciparum malaria
US HEALTH8 citations71
US5980899ANov 9, 1999
Identification of peptides that stimulate hepatitis C virus specific cytotoxic T cells
US HEALTH13 citations70
US6685944B1Feb 3, 2004
Modified HCV peptide vaccines
US HEALTH4 citations69
US5976541ANov 2, 1999
Potent peptide for stimulation of cytotoxic T lymphocytes specific for the HIV-1 envelope
US HEALTH14 citations66
US10286050B2May 14, 2019
Multi-epitope TARP peptide vaccine and uses thereof
US HEALTH2 citations65
US7541035B2Jun 2, 2009
Immunogenic peptides for the treatment of prostate and breast cancer
US HEALTH4 citations63
US7507538B2Mar 24, 2009
Human papilloma virus immunoreactive peptides
US HEALTH3 citations62
US7189513B2Mar 13, 2007
Human papilloma virus immunoreactive peptides
US HEALTH3 citations62
US7867977B2Jan 11, 2011
Immunogenic peptides and methods of use for treating and preventing cancer
US HEALTH2 citations59
US5882853AMar 16, 1999
Method of evaluating HTLV-I-specific T cell responses
US HEALTH3 citations59
US5695762ADec 9, 1997
Immunodominant sites of HTLV-I envelope protein
US HEALTH3 citations59
US5622703AApr 22, 1997
Immunodominant sites of HTLV-I envelope protein
US HEALTH4 citations59
US12268700B2Apr 8, 2025
3-o-sulfo-galactosylceramide analogs as activators of type II NKT cells and uses thereof
US HEALTH0 citations55
US11266726B2Mar 8, 2022
Compositions and methods for the treatment of HER2-expressing solid tumors
US HEALTH0 citations55
US9394352B2Jul 19, 2016
Immunogenic POTE peptides and methods of use
US HEALTH0 citations51
US7731971B2Jun 8, 2010
Enhanced CTL epitope-containing HIV-1 reverse transcriptase polypeptides
US HEALTH0 citations51
US10876955B2Dec 29, 2020
Optical configuration methods for spectral scatter flow cytometry
US HEALTH1 citations50
US9206245B2Dec 8, 2015
Immunogenic peptides and methods of use for treating and preventing cancer
US HEALTH0 citations49
US7074410B2Jul 11, 2006
Modified HCV peptide vaccines
US HEALTH0 citations48
US7691579B2Apr 6, 2010
Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen
US HEALTH0 citations45
US12083448B2Sep 10, 2024
Purification and labeling of extracellular vesicles using a mixed mode resin composition
US HEALTH0 citations38
BERZOFSKY JAY A
5 patentsUS8835613B2Sep 16, 2014
β-mannosylceramide and stimulation of NKT cell anti-tumor immunity
BERZOFSKY JAY A13 citations88
US9421254B2Aug 23, 2016
Immunostimulatory combinations of TLR ligands and methods of use
BERZOFSKY JAY A9 citations78
US8877914B2Nov 4, 2014
Compositions comprising nucleic acids encoding HIV-1 reverse transcriptase CTL epitopes
BERZOFSKY JAY A0 citations50
US8871902B2Oct 28, 2014
Immunogenic POTE peptides and methods of use
BERZOFSKY JAY A0 citations50
US8614304B2Dec 24, 2013
Immunogenic peptides and methods of use for treating and preventing cancer
BERZOFSKY JAY A0 citations47